Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Proc Natl Acad Sci U S A ; 112(16): 5099-104, 2015 Apr 21.
Article in English | MEDLINE | ID: mdl-25840590

ABSTRACT

Telomere syndromes have their most common manifestation in lung disease that is recognized as idiopathic pulmonary fibrosis and emphysema. In both conditions, there is loss of alveolar integrity, but the underlying mechanisms are not known. We tested the capacity of alveolar epithelial and stromal cells from mice with short telomeres to support alveolar organoid colony formation and found that type 2 alveolar epithelial cells (AEC2s), the stem cell-containing population, were limiting. When telomere dysfunction was induced in adult AEC2s by conditional deletion of the shelterin component telomeric repeat-binding factor 2, cells survived but remained dormant and showed all the hallmarks of cellular senescence. Telomere dysfunction in AEC2s triggered an immune response, and this was associated with AEC2-derived up-regulation of cytokine signaling pathways that are known to provoke inflammation in the lung. Mice uniformly died after challenge with bleomycin, underscoring an essential role for telomere function in AEC2s for alveolar repair. Our data show that alveoloar progenitor senescence is sufficient to recapitulate the regenerative defects, inflammatory responses, and susceptibility to injury that are characteristic of telomere-mediated lung disease. They suggest alveolar stem cell failure is a driver of telomere-mediated lung disease and that efforts to reverse it may be clinically beneficial.


Subject(s)
Pulmonary Alveoli/pathology , Stem Cells/pathology , Telomere Shortening , Telomere/pathology , Aging/pathology , Animals , Cell Differentiation , Cell Proliferation , Epithelial Cells/metabolism , Gene Deletion , Immunity , Inflammation/pathology , Intercellular Signaling Peptides and Proteins , Mesoderm/pathology , Mice , Paracrine Communication , Peptides/metabolism , Pulmonary Alveoli/metabolism , Pulmonary Surfactant-Associated Protein C , Signal Transduction/immunology , Spheroids, Cellular/pathology , Stromal Cells/pathology , Telomeric Repeat Binding Protein 2/metabolism , Tumor Suppressor Protein p53/metabolism
2.
Am J Respir Crit Care Med ; 184(8): 904-12, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-21757622

ABSTRACT

RATIONALE: Germline mutations in the enzyme telomerase cause telomere shortening, and have their most common clinical manifestation in age-related lung disease that manifests as idiopathic pulmonary fibrosis. Short telomeres are also a unique heritable trait that is acquired with age. OBJECTIVES: We sought to understand the mechanisms by which telomerase deficiency contributes to lung disease. METHODS: We studied telomerase null mice with short telomeres. MEASUREMENTS AND MAIN RESULTS: Although they have no baseline histologic defects, when mice with short telomeres are exposed to chronic cigarette smoke, in contrast with controls, they develop emphysematous air space enlargement. The emphysema susceptibility did not depend on circulating cell genotype, because mice with short telomeres developed emphysema even when transplanted with wild-type bone marrow. In lung epithelium, cigarette smoke exposure caused additive DNA damage to telomere dysfunction, which limited their proliferative recovery, and coincided with a failure to down-regulate p21, a mediator of cellular senescence, and we show here, a determinant of alveolar epithelial cell cycle progression. We also report early onset of emphysema, in addition to pulmonary fibrosis, in a family with a germline deletion in the Box H domain of the RNA component of telomerase. CONCLUSIONS: Our data indicate that short telomeres lower the threshold of cigarette smoke-induced damage, and implicate telomere length as a genetic susceptibility factor in emphysema, potentially contributing to its age-related onset in humans.


Subject(s)
Genetic Predisposition to Disease , Nicotiana/adverse effects , Pulmonary Emphysema/chemically induced , Pulmonary Emphysema/genetics , Smoke/adverse effects , Telomerase/genetics , Telomere/chemistry , Age Factors , Animals , Bone Marrow Transplantation , DNA Damage , Female , Fluorescent Antibody Technique , Idiopathic Pulmonary Fibrosis/enzymology , Idiopathic Pulmonary Fibrosis/genetics , Male , Mice , Mice, Inbred C57BL , Pulmonary Emphysema/enzymology , Pulmonary Emphysema/surgery , Real-Time Polymerase Chain Reaction , Respiratory Function Tests , Reverse Transcriptase Polymerase Chain Reaction , Telomerase/deficiency
3.
PLoS One ; 6(3): e17858, 2011 Mar 10.
Article in English | MEDLINE | ID: mdl-21423765

ABSTRACT

The genetic factors that underlie the increasing incidence of diabetes with age are poorly understood. We examined whether telomere length, which is inherited and known to shorten with age, plays a role in the age-dependent increased incidence of diabetes. We show that in mice with short telomeres, insulin secretion is impaired and leads to glucose intolerance despite the presence of an intact ß-cell mass. In ex vivo studies, short telomeres induced cell-autonomous defects in ß-cells including reduced mitochondrial membrane hyperpolarization and Ca(2+) influx which limited insulin release. To examine the mechanism, we looked for evidence of apoptosis but found no baseline increase in ß-cells with short telomeres. However, there was evidence of all the hallmarks of senescence including slower proliferation of ß-cells and accumulation of p16(INK4a). Specifically, we identified gene expression changes in pathways which are essential for Ca(2+)-mediated exocytosis. We also show that telomere length is additive to the damaging effect of endoplasmic reticulum stress which occurs in the late stages of type 2 diabetes. This additive effect manifests as more severe hyperglycemia in Akita mice with short telomeres which had a profound loss of ß-cell mass and increased ß-cell apoptosis. Our data indicate that short telomeres can affect ß-cell metabolism even in the presence of intact ß-cell number, thus identifying a novel mechanism of telomere-mediated disease. They implicate telomere length as a determinant of ß-cell function and diabetes pathogenesis.


Subject(s)
Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Signal Transduction , Telomere/pathology , Animals , Calcium Signaling/drug effects , Cell Survival/drug effects , Cellular Senescence/drug effects , Diabetes Mellitus/epidemiology , Diabetes Mellitus/etiology , Dyskeratosis Congenita/complications , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/pathology , Gene Expression Regulation/drug effects , Glucose/pharmacology , Glucose Tolerance Test , Humans , Incidence , Insulin/metabolism , Insulin Secretion , Insulin-Secreting Cells/drug effects , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics , Stress, Physiological/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL